Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #1457

    The new process, known as the Real-Time Oncology Review (RTOR) program, allows the agency to access key data prior to the official submission of the application, the FDA explained in a press release.This allows the review team "to begin their review earlier and communicate with the sponsor prior to the application's actual submission," said Richard Pazdur, MD, director of the FDA's Oncology Center of Excellence and acting director of the Office of Hematology and Oncology

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #1458

      When the sponsor submits the completed application, the review team will already be familiar with the data and be able to conduct a more efficient, timely and thorough review," he continued.In this case, the RTOR enabled the FDA to approve this indication within 2 weeks, he added.The new process was launched in July. Brentuximab is the fourth approval to emerge from the RTOR, noted the manufacturer.

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #1459

        Citat fra Medscape

        1 Reply Last reply
        0
        • H Offline
          H Offline
          hda
          wrote on sidst redigeret af
          #1460

          Sounds promising

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Plimsoller
            wrote on sidst redigeret af
            #1461

            Vil den godkendelsesprocedure også kunne anvendes ved sc?

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #1462

              Hvis data er meget stærke vil jeg tro den er med. Men et godt spørgsmål til JW.

              1 Reply Last reply
              0
              • P Offline
                P Offline
                Plimsoller
                wrote on sidst redigeret af
                #1463

                Det bliver så første gang jeg har formået at stille et spørgsmål til JW 😉

                1 Reply Last reply
                0
                • Legolas23L Offline
                  Legolas23L Offline
                  Legolas23
                  wrote on sidst redigeret af
                  #1464

                  Det vil han da ikke svare på. Mon ikke nogen har losset ham over skindebenet efter jeffries. Den var vist til kanten. JnJ har garanteret haft ham i røret.

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #1465

                    Husk nu at vores Q&A læses ude i den store verden. 🙂

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #1466

                      Det gør vores chat også. På analytics kan jeg se at den translateres til flere sprog hver dag.

                      1 Reply Last reply
                      0
                      • Legolas23L Offline
                        Legolas23L Offline
                        Legolas23
                        wrote on sidst redigeret af
                        #1467

                        Jeg kan bare frygte, han skubber svar videre til JnJ, men det bliver spændende at høre

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bibob
                          wrote on sidst redigeret af
                          #1468

                          Link Preview Image
                          Why Genmab A/S (CPH:GEN) Could Be Your Next Investment

                          favicon

                          (simplywall.st)

                          1 Reply Last reply
                          0
                          • D Offline
                            D Offline
                            Davor
                            wrote on sidst redigeret af
                            #1469

                            Det lyder som om det er ret sandsynligt at MAIA kommer ind under den der RTOR pilot ordning hvis der ikke er komplicerende faktorer i ansøgningen. Kan ikke lige se hvad det skulle være. Til gengæld stiller jeg mig tvivlsom overfor om så kan køre den vej. Der står vidst eksplicit at man ikke kan køre supplements med CMC ad den vej og det kan man vel næppe komme uden om med den nye formulering ...

                            1 Reply Last reply
                            0
                            • D Offline
                              D Offline
                              Davor
                              wrote on sidst redigeret af
                              #1470

                              SC skulle der stå i sidste del 🙂 . Bliver aldrig venner med autocorrect 🙂

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #1471

                                https://www.biospace.com/article/merck-s-keytruda-nabs-another-approval-this-one-under-fda-s-real-time-program/

                                1 Reply Last reply
                                0
                                • StockBullS Offline
                                  StockBullS Offline
                                  StockBull
                                  wrote on sidst redigeret af
                                  #1472

                                  Morn 🙂

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #1473

                                    @Solsen18.05. Ved $3.5bn siger mit regneark 2.3 mia kr i net profit som giver ESP 38kr, kurs 1580 ved PE42

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #1474

                                      Dara Royality: 3.5bn

                                      1 Reply Last reply
                                      0
                                      • StockBullS Offline
                                        StockBullS Offline
                                        StockBull
                                        wrote on sidst redigeret af
                                        #1475

                                        Omsætning 4.4mia kr, net indkomst 2,35mia kr, ESP 38kr - kurs ca. 1580kr

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #1476

                                          OFA 25mil kr, milestones 600 mil kr R&D 1.8mia

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger